Announced
Financials
Tags
United States
Acquisition
medical coatings
Private Equity
Private
Majority
Friendly
Single Bidder
Pending
Merger
Biotechnology
Domestic
Synopsis
Ampersand Capital Partners-backed N2 Biomedical, a provider of nano-engineered surface treatment and coating services, agreed to merge with Precision Coating, a medical coatings service provider. Financial terms were not disclosed. "We are very excited to add N2's technologies and people to Precision Coating. N2 extends our coating platform technologies in ways that enhance our value proposition for customers. This is particularly true in orthopedics, where we can now offer engineered coating solutions across both instruments and implants," Bill Ellerkamp, Precision Coating President.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.